Dose-finding Study of MT-1303

NCT01742052 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

415

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: MT-1303-Low
DRUG: MT-1303-Middle
DRUG: MT-1303-High
DRUG: Placebo

Sponsor

Tanabe Pharma Corporation